Cerus reported $66.66M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Atrion ATRI:US 13.35M 1.47M
Cerulean Pharma CERU:US $ 16.4M 0.34M
Cerus CERS:US $ 66.66M 11.9M
Cytori Therapeutics CYTX:US $ 4.92M 0.95M
GRIFOLS GRF:SM € 1921.48M 360.62M
Haemonetics HAE:US $ 442.27M 86.86M
Meridian Bioscience VIVO:US $ 56.46M 6.52M
Nuvasive NUVA:US $ 248.73M 47.84M
Orasure Technologies OSUR:US $ 55.59M 12.48M
Quidel QDEL:US $ 492.66M 169.14M
Sientra SIEN:US $ 84.65M 4.63M
Staar Surgical STAA:US $ 41.18M 7.62M
Terumo 4543:JP Y 177721M 10164M
Utah Medical Products UTMD:US $ 5.01M 448K